Oral iron chelation with deferiprone

O. Diav-Citrin; G. Koren

doi:10.1016/S0031-3955(05)70471-5

Oral iron chelation with deferiprone

O. Diav-Citrin
, G. Koren

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

This article summarizes the clinical experience with the new, orally active iron chelator, deferiprone, for transfusional iron-loaded patients with thalassemia and other refractory anemias. In addition, it reviews novel uses of iron chelation and potential new applications in acute iron poisoning.

Original language	English
Pages (from-to)	235-247
Number of pages	13
Journal	Pediatric Clinics of North America
Volume	44
Issue number	1
DOIs	https://doi.org/10.1016/S0031-3955(05)70471-5
State	Published - 1997
Externally published	Yes

Access to Document

10.1016/S0031-3955(05)70471-5

Cite this

@article{5c7920daec13475698a2c63d79207274,

title = "Oral iron chelation with deferiprone",

abstract = "This article summarizes the clinical experience with the new, orally active iron chelator, deferiprone, for transfusional iron-loaded patients with thalassemia and other refractory anemias. In addition, it reviews novel uses of iron chelation and potential new applications in acute iron poisoning.",

author = "O. Diav-Citrin and G. Koren",

note = "Funding Information: This work was supported by an MRC-Industry grant and by Apotex, Inc, Toronto. ",

year = "1997",

doi = "10.1016/S0031-3955(05)70471-5",

language = "אנגלית",

volume = "44",

pages = "235--247",

journal = "Pediatric Clinics of North America",

issn = "0031-3955",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Oral iron chelation with deferiprone

AU - Diav-Citrin, O.

AU - Koren, G.

N1 - Funding Information: This work was supported by an MRC-Industry grant and by Apotex, Inc, Toronto.

PY - 1997

Y1 - 1997

N2 - This article summarizes the clinical experience with the new, orally active iron chelator, deferiprone, for transfusional iron-loaded patients with thalassemia and other refractory anemias. In addition, it reviews novel uses of iron chelation and potential new applications in acute iron poisoning.

AB - This article summarizes the clinical experience with the new, orally active iron chelator, deferiprone, for transfusional iron-loaded patients with thalassemia and other refractory anemias. In addition, it reviews novel uses of iron chelation and potential new applications in acute iron poisoning.

UR - https://www.scopus.com/pages/publications/0031058489

U2 - 10.1016/S0031-3955(05)70471-5

DO - 10.1016/S0031-3955(05)70471-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 9057792

AN - SCOPUS:0031058489

SN - 0031-3955

VL - 44

SP - 235

EP - 247

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

IS - 1

ER -

Oral iron chelation with deferiprone

Abstract

Access to Document

Other files and links

Fingerprint

Cite this